ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,387Medicare Part D Prescriptions Filled, Including Refills

Rank: 349 out of 2061

$618K Total Retail Price of All Prescriptions

Rank: 461 out of 2061

430 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
21% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Ohio
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

6% of this provider’s 430 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

1% of this provider’s 10,464 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$54 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Ohio
LEVOTHYROXINE SODIUM 802 737 1 3
LISINOPRIL 521 442 2 2
SIMVASTATIN 463 429 3 1
AMLODIPINE BESYLATE 456 428 4 4
LOSARTAN POTASSIUM 402 384 5 17
METOPROLOL SUCCINATE 349 329 6 19
OMEPRAZOLE 335 307 7 5
FUROSEMIDE 275 265 8 6
ATENOLOL 235 225 9 13
ATORVASTATIN CALCIUM 227 199 10 8
POTASSIUM CHLORIDE 215 199 11 16
PRAVASTATIN SODIUM 187 183 12 14
FENOFIBRATE 176 148 13 65
GABAPENTIN 163 161 14 15
METOPROLOL TARTRATE 162 162 15 7
BENAZEPRIL HCL 161 161 16 124
JANUVIA 155 133 17 51
TRAMADOL HCL 151 142 18 18
SERTRALINE HCL 144 122 19 21
HYDROCHLOROTHIAZIDE 143 126 20 12
LOVASTATIN 139 130 21 35
LOSARTAN-HYDROCHLOROTHIAZIDE 132 132 22 50
ZOLPIDEM TARTRATE 131 118 23 23
METFORMIN HCL ER 110 93 24 71
PAROXETINE HCL 109 96 25 61
QUINAPRIL HCL 106 97 26 127
WARFARIN SODIUM 106 96 26 11
CRESTOR 105 102 28 31
ALLOPURINOL 100 100 29 28
HYDROCODONE-ACETAMINOPHEN 97 93 S3 30 10
RAMIPRIL 89 89 31 95
COUMADIN 74 74 32 218
TRIAMTERENE-HYDROCHLOROTHIAZID 73 64 33 135
ZETIA 72 72 34 68
NEXIUM 72 63 34 26
GLIPIZIDE ER 70 65 36 133
NATEGLINIDE 70 70 36 314
CITALOPRAM HBR 69 65 38 20
AZITHROMYCIN 69 59 38 34
FLUTICASONE PROPIONATE 67 65 40 43
DIOVAN 66 65 41 41
ALENDRONATE SODIUM 65 65 42 25
RANITIDINE HCL 65 61 42 53
CIPROFLOXACIN HCL 62 58 44 54
LORAZEPAM 60 60 45 96
PANTOPRAZOLE SODIUM 60 48 45 45
LANTUS 58 42 47 48
CLONIDINE HCL 56 55 48 52
DIGOXIN 55 55 49 56
SINGULAIR 55 43 49 88
ISOSORBIDE MONONITRATE ER 52 39 51 42
METFORMIN HCL 51 51 52 9
WELCHOL 50 47 53 239
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 6, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.